Prevention and treatment of acute mucosal damage to the stomach in intensive care units.
D000138:Acidosis / Q000188:drug therapy; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000628:therapy; D004750:Enteral Nutrition; D006801:Humans; D007362:Intensive Care Units; D007441:Intubation, Gastrointestinal; D010438:Peptic Ulcer Hemorrhage / Q000517:prevention & control*; D010952:Plasma Substitutes / Q000627:therapeutic use; D013004:Somatostatin / Q000627:therapeutic use; D013276:Stomach Ulcer / Q000150:complications / Q000517:prevention & control*; D013312:Stress, Physiological; D014667:Vasopressins / Q000627:therapeutic use
D000897:Anti-Ulcer Agents; D010952:Plasma Substitutes; D014667:Vasopressins; D013004:Somatostatin